About Products Technology Investors News Contact Us News You are here: Home / News Elanco Announces Agreement to Acquire Kindred Biosciences June 16, 2021 Bolt-on Acquisition Accelerates Elanco’s Expansion in Pet Health Elanco to host conference call for investment community at 8:00 am Eastern Time Elanco will acquire all outstanding stock of Kindred Biosciences at a price of $9.25 per share, or approximately $440 million, a premium of 52% based on the 30-day average. Transaction brings three potential […] Read more Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus June 2, 2021 Study demonstrated 100% survival in dogs treated with KIND-030, even in the absence of any supportive care, versus 43% survival in dogs treated with placebo San Francisco, California (June 2, 2021) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive results from a […] Read more Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI May 25, 2021 SAN FRANCISCO, May 25, 2021 — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the Stifel 2021 Virtual Jaws & Paws Conference on June 2 and the LD Micro Invitational XI on June 8. Dr. Richard Chin, Chief Executive Officer, will be available for one-on-one […] Read more Kindred Biosciences Announces First Quarter 2021 Financial Results May 11, 2021 San Francisco, California (May 11, 2021) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the first quarter ended March 31, 2021 and provided updates on its programs. For the first quarter 2021, KindredBio reported net revenues of $2.4 million and […] Read more Kindred Biosciences to Announce First Quarter 2021 Financial Results May 3, 2021 Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time on Tuesday, May 11, 2021. San Francisco, California (May 3, 2021) — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will release its first quarter 2021 financial results on May 11, […] Read more Page 1 of 35 1 2 3 › » KINDREDBIO NEWS Elanco Announces Agreement to Acquire Kindred Biosciences Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus Event: Kindred Biosciences to Present at the LD Micro Invitational XI Event: Kindred Biosciences to Present at the Stifel 2021 Virtual Jaws & Paws Conference Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI NEWS ARCHIVES June 2021 May 2021 April 2021 March 2021 February 2021 December 2020 November 2020 October 2020 September 2020 August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 December 2019 November 2019 October 2019 September 2019 August 2019 July 2019 May 2019 April 2019 March 2019 February 2019 January 2019 November 2018 October 2018 September 2018 August 2018 July 2018 June 2018 May 2018 April 2018 March 2018 February 2018 December 2017 November 2017 October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 November 2016 October 2016 September 2016 August 2016 July 2016 June 2016 May 2016 April 2016 March 2016 February 2016 January 2016 December 2015 November 2015 August 2015 May 2015 March 2015 December 2014 November 2014 August 2014 June 2014 May 2014 April 2014 March 2014 February 2014 December 2013 August 2013 July 2013 March 2013 February 2013 January 2013 NEWS Elanco Announces Agreement to Acquire Kindred Biosciences June 16, 2021 - 6:57 am Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus June 2, 2021 - 8:45 am Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XI May 25, 2021 - 8:57 am EVENTS Event: Kindred Biosciences to Present at the LD Micro Invitational XI May 25, 2021 - 9:14 am Event: Kindred Biosciences to Present at the Stifel 2021 Virtual Jaws & Paws Conference May 25, 2021 - 9:12 am Event: Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial Results March 8, 2021 - 8:48 am Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements © Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010